NO20054285L - Anvendelse av trombin inhibitorer med lav molekylvekt i kolesterol-reduserede terapi - Google Patents

Anvendelse av trombin inhibitorer med lav molekylvekt i kolesterol-reduserede terapi

Info

Publication number
NO20054285L
NO20054285L NO20054285A NO20054285A NO20054285L NO 20054285 L NO20054285 L NO 20054285L NO 20054285 A NO20054285 A NO 20054285A NO 20054285 A NO20054285 A NO 20054285A NO 20054285 L NO20054285 L NO 20054285L
Authority
NO
Norway
Prior art keywords
molecular weight
low molecular
cholesterol
thrombin inhibitors
weight thrombin
Prior art date
Application number
NO20054285A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054285D0 (no
Inventor
Margaretha Grind
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20054285D0 publication Critical patent/NO20054285D0/no
Publication of NO20054285L publication Critical patent/NO20054285L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NO20054285A 2003-03-22 2005-09-16 Anvendelse av trombin inhibitorer med lav molekylvekt i kolesterol-reduserede terapi NO20054285L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0306615.6A GB0306615D0 (en) 2003-03-22 2003-03-22 New use
PCT/SE2004/000417 WO2004082702A1 (en) 2003-03-22 2004-03-19 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy

Publications (2)

Publication Number Publication Date
NO20054285D0 NO20054285D0 (no) 2005-09-16
NO20054285L true NO20054285L (no) 2005-10-20

Family

ID=9955311

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054285A NO20054285L (no) 2003-03-22 2005-09-16 Anvendelse av trombin inhibitorer med lav molekylvekt i kolesterol-reduserede terapi

Country Status (17)

Country Link
US (1) US20060183692A1 (https=)
EP (1) EP1608311B1 (https=)
JP (1) JP2006520813A (https=)
KR (1) KR20050114237A (https=)
CN (1) CN1761479A (https=)
AT (1) ATE475417T1 (https=)
AU (1) AU2004222409B2 (https=)
BR (1) BRPI0408522A (https=)
CA (1) CA2517191A1 (https=)
DE (1) DE602004028348D1 (https=)
ES (1) ES2346969T3 (https=)
GB (1) GB0306615D0 (https=)
MX (1) MXPA05010159A (https=)
NO (1) NO20054285L (https=)
NZ (1) NZ542505A (https=)
WO (1) WO2004082702A1 (https=)
ZA (1) ZA200507614B (https=)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1237518B (it) * 1989-11-24 1993-06-08 Renato Conti Eparine supersolfatate
AU714985B2 (en) * 1996-04-23 2000-01-13 Merck & Co., Inc. Pyrazinone thrombin inhibitors
WO1998011896A1 (en) * 1996-09-18 1998-03-26 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
AR023510A1 (es) * 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
US6462021B1 (en) * 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
US7470538B2 (en) * 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
US7371759B2 (en) * 2003-09-25 2008-05-13 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method

Also Published As

Publication number Publication date
WO2004082702A1 (en) 2004-09-30
KR20050114237A (ko) 2005-12-05
WO2004082702A8 (en) 2005-03-24
ES2346969T3 (es) 2010-10-22
CA2517191A1 (en) 2004-09-30
GB0306615D0 (en) 2003-04-30
ZA200507614B (en) 2006-06-28
MXPA05010159A (es) 2005-11-16
NO20054285D0 (no) 2005-09-16
DE602004028348D1 (de) 2010-09-09
US20060183692A1 (en) 2006-08-17
BRPI0408522A (pt) 2006-03-07
EP1608311B1 (en) 2010-07-28
NZ542505A (en) 2009-01-31
HK1084329A1 (en) 2006-07-28
AU2004222409B2 (en) 2007-03-08
AU2004222409A1 (en) 2004-09-30
CN1761479A (zh) 2006-04-19
EP1608311A1 (en) 2005-12-28
ATE475417T1 (de) 2010-08-15
JP2006520813A (ja) 2006-09-14

Similar Documents

Publication Publication Date Title
Grainger et al. Medical management of osteoarthritis of the knee and hip joints
WO2002028379A3 (en) Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases
GEP20084567B (en) Carbostyril derivatives and mood stabilizers for treating mood disorders
BR0013704A (pt) Uso de inibidores do sistema renina-angiotensina na prevenção de casos cardiovasculares
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
IS5826A (is) Forlyf róteindardælu lata
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
CY1112981T1 (el) Μεθοδος και συνθεση για την αγωγη της ρινιτιδας
NO20092527L (no) Prolegemidler, fremgangsmate for fremstilling og anvendelse derav
WO2007131168A3 (en) Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
PA8555401A1 (es) Derivados de quinolina
NO20084187L (no) Medikamenter og proteiner
WO2008145842A3 (fr) Dérivés de triazolopyridine-carboxamides, leur préparation et leur application en thérapeutique
MY128061A (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug
NO20080133L (no) Azolopyridin-2-on derivater som lipase og fosfolipaseinhibitorer
WO2005016249A3 (en) Compositions of a chromene or phenyl acetic acid cyclooxygenase-2 selective inhibitor and an ace inhibitor for the treatment of central nervous system damage
NO20013301D0 (no) Ny dialysemetode
NO20055474L (no) Mediatorer av revers kolesteroltransport for behandling av hyperkolesterolemi
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer
MXPA02010184A (es) Formulaciones topicas para el suministro transdermico de niacina y metodos para tratar hiperlipidemia.
NO20054285L (no) Anvendelse av trombin inhibitorer med lav molekylvekt i kolesterol-reduserede terapi
IL175358A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
NO20052313L (no) Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av
WO2005079772A3 (en) Combination of (s)-amlodipine and an ace inhibitor, and methods for reducing hypertension

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application